Subjects, methods, and results
We studied 26 patients receiving renal dialysis (16 from the Netherlands, 10 from Northern Ireland). Blood samples were taken before dialysis and the separated serum assayed for creatinine and digoxia concentrations using assays routinely employed in the respective hospital laboratories. At the time of the study none of the patients was receiving digoxin. The table shows the age and sex of the patients and their serum creatinine concentrations. When analyses were complete at one centre the samples were exchanged and reassayed at the other centre. The methods used included two radioimmunoassay techniques (Amerlex, Amersham International, England; DPC, the Netherlands), a fluorometric enzyme immunoassay (Stratus, USA), and a fluorescence polarisation immunoassay (Abbott Diagnostics, USA). The samples from the Netherlands (cases 1-16) were also assayed using fluorescence energy transfer immunoassay (Syva, USA). With the exception of the fluorescence polarisation technique, which was used in the liver disease report,' none of the methods had been tested for cross reactivity with endogenous immunoreactive substances in serum. In all cases the assay techniques yielded negative digoxin values (detection limit 256 pmol/l (0-2 ng/ml)).
Data on patients whose serum was assayed for digoxin like immunoreactive substance using range of immunoassay techniques. 
